Cecilie Delphin Amdal
- Group leader, consultant; MD, PhD
Publications 2024
Chronic fatigue in long-term survivors of head and neck cancer treated with radiotherapy
Radiother Oncol, 195, 110231
DOI 10.1016/j.radonc.2024.110231, PubMed 38518958
The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change
Eur J Cancer, 212, 115062
DOI 10.1016/j.ejca.2024.115062, PubMed 39405647
Long-term health-related quality of life in head and neck cancer survivors: A large multinational study
Int J Cancer, 154 (10), 1772-1785
DOI 10.1002/ijc.34861, PubMed 38312044
Publications 2023
Impact of hyperfractionated re-irradiation on quality of life in patients with recurrent or second primary head and neck cancer, a prospective single institutional study
Clin Transl Radiat Oncol, 42, 100654
DOI 10.1016/j.ctro.2023.100654, PubMed 37415638
Radiation-induced long-term dysphagia in survivors of head and neck cancer and association with dose-volume parameters
Radiother Oncol, 190, 110044
DOI 10.1016/j.radonc.2023.110044, PubMed 38061420
Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice
Lancet Oncol, 24 (5), e197-e206
DOI 10.1016/S1470-2045(23)00110-9, PubMed 37142381
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
Lancet Oncol, 24 (6), e270-e283
DOI 10.1016/S1470-2045(23)00157-2, PubMed 37269858
Serious Long-Term Effects of Head and Neck Cancer from the Survivors' Point of View
Healthcare (Basel), 11 (6)
DOI 10.3390/healthcare11060906, PubMed 36981562
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Crit Care, 27 (1), 9
DOI 10.1186/s13054-022-04205-8, PubMed 36627655
Publications 2022
A multicenter international prospective study of the validity and reliability of a COVID-19-specific health-related quality of life questionnaire
Qual Life Res, 32 (2), 447-459
DOI 10.1007/s11136-022-03272-2, PubMed 36273365
Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measure
J Patient Rep Outcomes, 6 (1), 26
DOI 10.1186/s41687-022-00434-1, PubMed 35348945
Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy
J Cancer Surviv, 17 (4), 1082-1093
DOI 10.1007/s11764-022-01273-1, PubMed 36350483
Proteomic Profiling of Saliva and Tears in Radiated Head and Neck Cancer Patients as Compared to Primary Sjögren's Syndrome Patients
Int J Mol Sci, 23 (7)
DOI 10.3390/ijms23073714, PubMed 35409074
Body image concerns in long-term head and neck cancer survivors: prevalence and role of clinical factors and patient-reported late effects
J Cancer Surviv, 17 (2), 526-534
DOI 10.1007/s11764-022-01311-y, PubMed 36509859
Publications 2021
Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review
Qual Life Res, 30 (12), 3367-3381
DOI 10.1007/s11136-021-02908-z, PubMed 34146226
Comparing the use of patient-reported outcomes in clinical studies in Europe in 2008 and 2018: a literature review
Qual Life Res, 31 (3), 659-669
DOI 10.1007/s11136-021-02946-7, PubMed 34350566
Alterations in meibomian glands in patients treated with intensity-modulated radiotherapy for head and neck cancer
Sci Rep, 11 (1), 22419
DOI 10.1038/s41598-021-01844-9, PubMed 34789830
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale
Qual Life Res, 31 (3), 841-853
DOI 10.1007/s11136-021-02939-6, PubMed 34272632
Oral and ocular late effects in head and neck cancer patients treated with radiotherapy
Sci Rep, 11 (1), 4026
DOI 10.1038/s41598-021-83635-w, PubMed 33597629
Publications 2020
Cytokines Explored in Saliva and Tears from Radiated Cancer Patients Correlate with Clinical Manifestations, Influencing Important Immunoregulatory Cellular Pathways
Cells, 9 (9)
DOI 10.3390/cells9092050, PubMed 32911805
Long-term outcome in patients operated with hybrid esophagectomy for esophageal cancer - a cohort study
Acta Oncol, 59 (7), 859-865
DOI 10.1080/0284186X.2020.1750694, PubMed 32324079
Publications 2019
The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status
Radiother Oncol, 140, 54-61
DOI 10.1016/j.radonc.2019.05.019, PubMed 31177043
International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV
Head Neck, 41 (6), 1725-1737
DOI 10.1002/hed.25609, PubMed 30636188
Publications 2018
Patients know their own health best
Tidsskr. Nor. Laegeforen., 138 (8), 716-718
[Patients know their own health best]
Tidsskr Nor Laegeforen, 138 (8)
DOI 10.4045/tidsskr.17.1054, PubMed 29737772
Dose painting for re-irradiation of head and neck cancer
Acta Oncol, 57 (12), 1693-1699
DOI 10.1080/0284186X.2018.1512753, PubMed 30280623
Publications 2017
Improved treatment decisions in patients with esophageal cancer
Acta Oncol, 56 (10), 1286-1294
DOI 10.1080/0284186X.2017.1346379, PubMed 28686501
Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer
Radiat Oncol, 12 (1), 87
DOI 10.1186/s13014-017-0829-5, PubMed 28545588
Publications 2014
Are surrogate endpoints useful in clinical studies?
Tidsskr Nor Laegeforen, 134 (11), 1128-9
DOI 10.4045/tidsskr.14.0411, PubMed 24939776
Publications 2013
Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial
Radiother Oncol, 107 (3), 428-33
DOI 10.1016/j.radonc.2013.04.008, PubMed 23647761
Publications 2012
Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review
Acta Oncol, 52 (4), 679-90
DOI 10.3109/0284186X.2012.731521, PubMed 23190360
Publications 2011
Palliative interventions and prognosis in patients with advanced esophageal cancer
Dis Esophagus, 24 (7), 502-9
DOI 10.1111/j.1442-2050.2010.01174.x, PubMed 21309923
Publications 2010
Radical treatment for oesophageal cancer patients unfit for surgery and chemotherapy. A 10-year experience from the Norwegian Radium Hospital
Acta Oncol, 49 (2), 209-18
DOI 10.3109/02841860903246573, PubMed 19929566